Question to the Department of Health and Social Care:

To ask the Secretary of State for Health and Social Care, what steps his Department is taking to (a) help tackle shortages of epilepsy medication and (b) ensure patients have consistent access to their prescribed treatment.

The Department is working hard with industry to help resolve intermittent supply issues with some epilepsy medications. As a result of ongoing activity and intensive work, including directing suppliers to expedite deliveries, most issues, including with carbamazepine, lamotrigine and oxcarbazepine presentations, have been resolved.

We are currently aware of an ongoing supply issue with all strengths of topiramate tablets from one manufacturer. This supply issue is expected to resolve by the end of May 2025. We are also aware of a shortage of phenobarbital 15 milligram tablets from one manufacturer with the resupply date to be confirmed. In both cases, alternative suppliers are in stock with sufficient supply to support patients. These issues have been communicated to the National Health Service.